Bulk analysis of renal allograft biopsies (rBx) identified RNA transcripts associated with acute cellular rejection (ACR); however, these lacked cellular context critical to mechanistic understanding. We performed combined single cell RNA transcriptomic and TCRα/β sequencing on rBx from patients with ACR under differing immunosuppression (IS): tacrolimus, iscalimab, and belatacept. TCR analysis revealed a highly restricted CD8 T cell clonal expansion (CD8 ), independent of HLA mismatch or IS type. Subcloning of TCRα/β cDNAs from CD8 into Jurkat76 cells (TCR ) conferred alloreactivity by mixed lymphocyte reaction. scRNAseq analysis of CD8 revealed effector, memory, and exhausted phenotypes that were influenced by IS type. Successful anti-rejection treatment decreased, but did not eliminate, CD8 , while CD8 were maintained during treatment-refractory rejection. Finally, most rBx-derived CD8 were also observed in matching urine samples. Overall, our data define the clonal CD8 T cell response to ACR, providing novel insights to improve detection, assessment, and treatment of rejection.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934650 | PMC |
http://dx.doi.org/10.1101/2023.02.08.524808 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!